Objective
Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated among the six most promising Key Enabling Technologies, is one of the most important emerging areas of health research expected to contribute to one of the strategic challenges that Europe has to face in the future: Provide effective and affordable health care and assure the wellbeing of an increasingly aged population.
EuroNanoMed III (ENM III) builds on the foundations of ENM I & II, which launched 7 successful joint calls for proposals since 2009, funded 51 transnational research projects involving 269 partners from 25 countries/regions, and allocated € 45,5 million to research projects from ENM funding agencies. ENM III consortium, reinforced with 12 new partners from Europe, Canada and Taiwan, is committed to fostering the competiveness of European nanomedicine actors taking into account recent changes in the landscape and new stakeholders and challenges, as identified in the SRIA in nanomedicine. The first joint call for proposals will be co-funded by ENM III partners and the EC. After the co-funded call, three additional joint transnational calls will be organized and strategic activities will be accomplished in collaboration with key initiatives in the field. ENM III actions focus on translatability of project results to clinical and industry needs.
Keywords
Programme(s)
Funding Scheme
ERA-NET-Cofund - ERA-NET CofundCoordinator
28029 Madrid
Spain
See on map
Participants (28)
1000 Bruxelles / Brussel
See on map
51004 Tartu
See on map
75013 Paris
See on map
53175 Bonn
See on map
40468 Duesseldorf
See on map
D02 Dublin
See on map
9101002 Jerusalem
See on map
00144 Roma
See on map
Participation ended
00153 Roma
See on map
1050 Riga
See on map
LT-01103 Vilnius
See on map
3527 JP Utrecht
See on map
0283 Oslo
See on map
00-801 WARSZAWA
See on map
1249 074 Lisboa
See on map
010168 Bucuresti
See on map
010362 Bucuresti
See on map
814 38 Bratislava
See on map
28001 Madrid
See on map
Participation ended
28046 Madrid
See on map
06100 Ankara
See on map
115 10 ATHENS
See on map
H3A3C6 Montreal Quebec
See on map
106 Taipei
See on map
160 00 Praha
See on map
1000 Sofia
See on map
28071 Madrid
See on map
00153 Roma
See on map